Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Gerresheimer AGGRRMF 64 Earnings per Share (Diluted) is $-10.68 as of Nov. 2025. GuruFocus rates GRRMF with a GF Score™ of 64/100 and a GF Value™ of $191.45 (Possible Value Trap). The stock has 6 warning signs investors should review. Among 658 Medical Devices & Instruments companies, Gerresheimer AG ranks worse than 151975.53% on this metric.
Gerresheimer AG's EPS (Basic) for the
three
months ended in Nov. 2025 was $-10.25.
Its EPS (Basic) for the trailing twelve months (TTM) ended in Nov. 2025 was $-10.68.
During the past 13 years, Gerresheimer AG's highest 3-Year average EPS without NRI Growth Rate was 116.80% per year. The lowest was -12.30% per year. And the median was 15.60% per year.
Gerresheimer AG (OTCPK:GRRMF) Earnings per Share (Diluted) Explanation
Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.
Be Aware
Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.
If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.
Gerresheimer AG Earnings per Share (Diluted) Related Terms
Gerresheimer AG Earnings per Share (Diluted) Historical Data
* Premium members only.
The historical data trend for Gerresheimer AG's Earnings per Share (Diluted) can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gerresheimer AG Earnings per Share (Diluted) Chart
GRRMF vs ISRG, BDX, RMD: Earnings per Share (Diluted) Comparison
For the Medical Instruments & Supplies subindustry, Gerresheimer AG's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gerresheimer AG PE Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gerresheimer AG's PE Ratio distribution charts can be found below:
* The bar in red indicates where Gerresheimer AG's PE Ratio falls into.
Gerresheimer AG Earnings per Share (Diluted) Calculation
Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.
Gerresheimer AG's Earnings Per Share (Diluted) for the fiscal year that ended in Nov. 2025 is calculated as
Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Nov. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-10.68
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.
What does a Earnings per Share (Diluted) of $-10.68 mean?
Gerresheimer AG (GRRMF) has a Earnings per Share (Diluted) of $-10.68 as of Nov. 2025. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Gerresheimer AG and its competitors. According to the industry distribution chart, Gerresheimer AG ranks #999999 out of 658 companies in the Medical Devices & Instruments industry.
Is Gerresheimer AG's Earnings per Share (Diluted) too high?
Gerresheimer AG's current Earnings per Share (Diluted) is $-10.68. Based on the distribution chart, Gerresheimer AG ranks #999999 out of 658 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Gerresheimer AG has a GF Score™ of 64/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gerresheimer AG's Earnings per Share (Diluted) compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Gerresheimer AG ranks #999999 out of 658 companies for Earnings per Share (Diluted). This places Gerresheimer AG in the lower half of its industry. The industry median Earnings per Share (Diluted) is 7.90. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Earnings per Share (Diluted) for a Medical Devices & Instruments company?
The median Earnings per Share (Diluted) among Medical Devices & Instruments companies is 7.90, based on 658 companies in the industry. Companies in the top quartile (top 25%) have a Earnings per Share (Diluted) significantly above this median, while those in the bottom quartile fall well below. However, Earnings per Share (Diluted) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Earnings per Share (Diluted) mean?
A high Earnings per Share (Diluted) can signal that a stock is expensive relative to its fundamentals. Diluted EPS equals net earnings divided by average shares outstanding, including dilutive securities. View historical data on Gerresheimer AG and its competitors. For the Medical Devices & Instruments industry, the median Earnings per Share (Diluted) is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gerresheimer AG's current Earnings per Share (Diluted) is $-10.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gerresheimer AG stock overvalued right now?
Based on GuruFocus' analysis, Gerresheimer AG (GRRMF) is currently considered Possible Value Trap. The stock's GF Value™ is $191.45, compared to a current price of $32.20 — trading 83.2% below its estimated fair value. The current Earnings per Share (Diluted) is $-10.68. Gerresheimer AG's overall GF Score™ is 64/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Earnings per Share (Diluted) calculated?
Earnings per Share (Diluted) is calculated from a company's financial statements. For Gerresheimer AG (GRRMF), the current Earnings per Share (Diluted) is $-10.68 as of Nov. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Gerresheimer AG (GRRMF) Overvalued in 2026?
Based on GuruFocus' analysis, Gerresheimer AG stock appears to be undervalued.
The current stock price of $32.20 is trading 83.2% below its estimated GF Value™ of $191.45.
GuruFocus considers Gerresheimer AG to be Possible Value Trap.
Key valuation signals for GRRMF:
Earnings per Share (Diluted): $-10.68
GF Value™: $191.45 vs. price of $32.20 (83.2% below fair value)
No single metric tells the full story. See the GRRMF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Gerresheimer AG provides medicine packaging, drug delivery devices, and solutions with a product range for pharma, health, well-being, and biotech. The firm operates in three segments: The plastics and devices segment consists of products for simple and safe drug delivery along with packaging for liquid and solid medicines, The primary packaging glass segment produces glass packaging products for the pharma and cosmetics industries also for food and beverage industry and The advanced technologies segment works on technical and digital solutions to improve the therapy outcome for patients. The company generates the majority of its revenue in Europe, with sales in Germany contributing the major proportion of any country.
64GF Score
Get the complete analysis for GRRMF
Earnings per Share (Diluted) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
GRRMF has been successfully added to your 
